Legal Representation
Attorney
Gina A. Bibby
USPTO Deadlines
Next Deadline
182 days overdue
NOA E-Mailed - SOU Required
Due Date
June 24, 2025
Extension Available
Until December 24, 2025
Application History
10 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 28, 2025 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Jul 28, 2025 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Dec 24, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Nov 12, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Nov 12, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 23, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 2, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 19, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 19, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 6, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for treatment of muscle disease including, but not limited to, Facioscapulohumeral Muscular Dystrophy/Atrophy
Class 042
Clinical research in the field of Facioscapulohumeral Muscular Dystrophy/Atrophy; Testing, inspection, research, or development of pharmaceutical preparations for treatment of Facioscapulohumeral Muscular Dystrophy/Atrophy; Pharmaceutical products development; Development of pharmaceutical preparations and medicines
Class 044
Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals
Classification
International Classes
005
042
044